Covered recipient · General Payments record
SHIVA ARAMI
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$572.03
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $492.43 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $157.78 | 7 |
| Amgen Inc. | $105.17 | 4 |
| ABBVIE INC. | $85.62 | 3 |
| E.R. Squibb & Sons, L.L.C. | $52.34 | 1 |
| GlaxoSmithKline, LLC. | $45.20 | 2 |
| Janssen Biotech, Inc. | $26.20 | 1 |
| Kiniksa Pharmaceuticals International, plc | $20.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.89 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103235225 | CMS |
| ABBVIE INC. | $25.74 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103235227 | CMS |
| ABBVIE INC. | $29.99 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103235229 | CMS |
| Amgen Inc. | $34.30 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115427687 | CMS |
| Amgen Inc. | $21.19 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117495988 | CMS |
| Amgen Inc. | $22.76 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117495990 | CMS |
| Amgen Inc. | $26.92 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117495992 | CMS |
| E.R. Squibb & Sons, L.L.C. | $52.34 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101335226 | CMS |
| GlaxoSmithKline, LLC. | $19.41 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116107958 | CMS |
| GlaxoSmithKline, LLC. | $25.79 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116457357 | CMS |
| Janssen Biotech, Inc. | $26.20 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078575570 | CMS |
| Kiniksa Pharmaceuticals International, plc | $20.12 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154885574 | CMS |
| PFIZER INC. | $20.09 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131631155 | CMS |
| PFIZER INC. | $25.22 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131587150 | CMS |
| PFIZER INC. | $23.64 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131603993 | CMS |
| PFIZER INC. | $14.05 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132035544 | CMS |
| PFIZER INC. | $25.99 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131955480 | CMS |
| PFIZER INC. | $25.76 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131978079 | CMS |
| PFIZER INC. | $23.03 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132132065 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.